2015 In Review: Tension Builds At The Regulatory Cosmetic/Drug Divide

FDA continued its crackdown on overreaching cosmetic claims in 2015, issuing nine warnings to cosmetic product marketers, while a draft bill emerged in the US House that would redefine "cosmetic" under federal law to provide companies with greater flexibility. Microbead legislation commanded the most national attention, with President Obama signing the federal Microbead-Free Waters Act to close out the year.